With an estimated $320+ billion dollars in lost revenue for 2020, the COVID-19 pandemic has created a challenging combination of revenue constraints and rising costs for IDNs nationwide. Prior to the pandemic, supply chains focused on cost-control, just-in-time supplies, and standardization. Under current financial difficulties, what changes to previous ways of doing business must be made? Where does cost fall on your priority list in post-pandemic contracting? Where can supply chain leaders find future expense savings? Join this panel for an interactive discussion on strategies to improve your IDNs bottom line.

Learning Objectives:

1. Identify methods of how supply chain leaders engage internal and external stakeholders.
2. Evaluate chances for savings with both clinical and non-clinical expenditures.
3. Outline opportunities for improved product, service, and technology evidence-based decision making.